Actively Recruiting

Phase 1
Phase 2
Age: 60Years - 89Years
All Genders
Healthy Volunteers
ID07130669

A Facial Expression-based Personalization Engine for Monitoring and Modulating Engagement in Cognitive Training in Older Adults at Risk for Alzheimer's Disease or Related Dementias

Led by Stanford University · Updated on 2026-04-24

80

Participants Needed

1

Research Sites

13 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying how to improve adherence to computerized cognitive training done at home by older adults at risk for Alzheimer's disease or related dementias. This study tests a facial expression-based personalization engine (FPE) designed to monitor and adjust training in real time, aiming to keep participants effectively engaged and enhance long-term adherence. The study compares cognitive training programs with and without this FPE in older adults at risk for cognitive decline. Participants will engage in a six-week unsupervised cognitive training program called speed of processing training. One group will use the FPE system that tracks facial expressions to assess engagement and modulates task novelty accordingly, while the other group will use traditional computerized cognitive training without this personalized feedback. The study evaluates how this approach influences engagement and adherence. Throughout the intervention, researchers will measure a multi-modal effective engagement index continuously over up to eight weeks. Other assessments include time spent training, self-reported fatigue, memory, and executive function at baseline, post-intervention, and at follow-up six weeks later. The study is randomized and double-blind, with participation possible for adults aged 60 to 89, and includes monitoring to understand how engagement impacts cognitive outcomes.

CONDITIONS

Brief Title

FACE Phase II (a Stage II Trial)

Who Can Participate

Age: 60Years - 89Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • English speaking
  • Aged 60 to 89 years
  • Living in a home, or independent- or assisted-living facility
  • Adequate visual and hearing acuity
  • Stable use of antidepressants, antipsychotics, or anxiolytics for at least 7 days
  • Stable use of memory medications for at least 3 months
  • No neurological or vascular disorders except minor symptoms approved case-by-case
Not Eligible

You will not qualify if you...

  • Currently enrolled in another intervention study aimed at improving cognition
  • Living in a nursing home
  • Diagnosed with Multiple Sclerosis, traumatic brain injury, chronic heart failure, Parkinson's disease, or dementia

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 6 weeks

Participants undergo a 6-week cognitive training intervention using either a personalized facial expression-based interface or traditional computerized training.

Multiple sessions throughout the 6 weeks

Follow-up

Duration - 6 weeks after intervention

Participants complete post-intervention and follow-up assessments of memory and executive function.

2 visits (post-intervention at week 7 and follow-up at week 13)

Trial Site Locations

Total: 1 location

1

Stanford University CogT Lab

Palo Alto, California, United States, 94304-0000

Actively Recruiting

Loading map...

Research Team

F

Feng Vankee Lin, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Similar Trials

A Feasibility Study of Green Activity Program for People Liv...

Mild Cognitive Impairment

Actively Recruiting

1 location

A Non Randomized, Open-Label Phase I Study to Evaluate the S...

AD - Alzheimer's Disease

Actively Recruiting

1 location

Early-phase Biomarker-based Trial of NPC-1 for Alzheimer's D...

Alzheimer Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here